[Anti-oxidative effects of anti-hypertensive drugs].
Okumura
Midori
M
Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University, Graduate School of Medicine.
Iwai
Masaru
M
Horiuchi
Masatsugu
M
Ito
Masaharu
M
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004232:Diuretics / Q000494:pharmacology; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D018384:Oxidative Stress
D000317:Adrenergic alpha-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D000975:Antioxidants; D002121:Calcium Channel Blockers; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D009569:Nitric Oxide